Ranirestat

Ranirestat (also known as AS-3201) is an aldose reductase inhibitor being developed for the treatment of diabetic neuropathy by Dainippon Sumitomo Pharma and PharmaKyorin. It has been granted orphan drug status. The drug is to be used orally.
Wikipedia contributors, "Ranirestat", Wikipedia, revision 1369496039, retrieved 20 November 2026, source, CC BY-SA 4.0.